Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Commons

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
BMJ Open Diabetes Research & Care|February 27, 2026
Management and outcomes of people presenting with new diabetes-related foot infections: a prospective observational study from Australia and New ZealandEdward Raby, Laurens Manning, Kate McCarthy, et al.
Plos Medicine|September 27, 2024
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysisIhsan Fadilah, Robert J Commons, Nguyen Hoang Chau, et al.
BMJ Global Health|December 20, 2023
Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysisReena Verma, Robert J Commons, Apoorv Gupta, et al.
Malaria Journal|June 6, 2026
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysisTamiru Shibiru Degaga, Kamala Thriemer, Megha Rajasekhar, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Malaria Journal|June 12, 2025
Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting reportManash Shrestha, Sanjaya Acharya, Josselyn Neukom, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
BMJ Open Diabetes Research & Care|February 27, 2026
Management and outcomes of people presenting with new diabetes-related foot infections: a prospective observational study from Australia and New ZealandEdward Raby, Laurens Manning, Kate McCarthy, et al.
Plos Medicine|September 27, 2024
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysisIhsan Fadilah, Robert J Commons, Nguyen Hoang Chau, et al.
BMJ Global Health|December 20, 2023
Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysisReena Verma, Robert J Commons, Apoorv Gupta, et al.
Malaria Journal|June 6, 2026
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysisTamiru Shibiru Degaga, Kamala Thriemer, Megha Rajasekhar, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Malaria Journal|June 12, 2025
Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting reportManash Shrestha, Sanjaya Acharya, Josselyn Neukom, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
Pageof 6